Type A Insulin Resistance Syndrome: A Patient Guide
At a Glance
Type A Insulin Resistance Syndrome is a rare inherited condition caused by an INSR gene mutation. It can cause severe insulin resistance, high insulin, blood sugar swings, acanthosis nigricans, and reproductive symptoms, so diagnosis supports personalized care.
Type A Insulin Resistance Syndrome (TAIRS) is a rare genetic condition that fundamentally changes how your body interacts with one of its most vital hormones: insulin. In a typical metabolic system, insulin acts like a key that opens “locks” called insulin receptors on the surface of your cells, allowing sugar to enter and provide energy. For those living with TAIRS, a mutation in the INSR gene means these locks have a defect that reduces their function, preventing the signal from getting through [1]. This leads to a state of extreme insulin resistance where the body produces massive amounts of the hormone to compensate, yet the cells remain unable to respond effectively [2].
Because this condition is genetic rather than lifestyle-driven, it follows a unique pattern that often confuses standard medical assessments. While TAIRS can affect individuals across the weight spectrum, being naturally lean is a frequent clue [3]. The symptoms often become most apparent during puberty, particularly for females, who may experience irregular menstrual cycles, persistent acne, and excess hair growth—a cluster of signs that leads many to be misdiagnosed for years with Polycystic Ovary Syndrome (PCOS) [4]. A hallmark physical sign of the condition is acanthosis nigricans, where the skin in areas like the neck and armpits becomes dark and velvety due to the high levels of insulin circulating in the blood [1].
Living with TAIRS often involves navigating a metabolic paradox known as the “dual nature” of blood sugar. While you may experience high blood sugar because your cells cannot absorb glucose, you are also at risk for sudden “crashes,” or postprandial hypoglycemia, a few hours after eating [5]. This happens because the enormous surge of insulin produced after a meal can eventually overpower the resistance, causing blood sugar to drop rapidly [6]. Understanding this cycle is essential for managing your daily energy and long-term health.
While a diagnosis of a rare genetic disorder can feel overwhelming, it provides a clear roadmap that was previously missing. Identifying the specific INSR mutation allows your medical team to move beyond general diabetes advice and toward a specialized plan that addresses your unique biology [7]. By focusing on stabilizing blood sugar swings and managing hormonal symptoms, you can work toward a balanced life with a care team that understands the specific challenges of your condition [8].
In this guide
6 chapters
Understanding Your Diagnosis: Type A Insulin Resistance Syndrome (TAIRS)
Learn what a TAIRS diagnosis means, including INSR mutations, severe insulin resistance, PCOS overlap, genetic testing, inheritance, and family screening.
Symptoms, Warning Signs, and the Blood Sugar Paradox
Learn how Type A insulin resistance causes skin and hormone changes, blood sugar highs and after-meal lows, and warning signs needing emergency care for TAIRS.
The Biology of TAIRS: Genes, Receptors, and Look-Alikes
Learn how Type A insulin resistance syndrome affects INSR receptors, differs from PCOS and Type B resistance, and why genetic testing matters for diagnosis.
The Lab Journey: Decoding Your Results
Learn how Type A insulin resistance syndrome is evaluated using insulin, C-peptide, lipid, and INSR genetic testing, including VUS results and exam findings.
Treatment Strategies: Balancing Blood Sugar and Hormones
Learn how Type A Insulin Resistance Syndrome is treated, including insulin, oral medicines, hormone therapies, nutrition, and CGM monitoring for safer control.
The Long View: Monitoring, Family, and Future Health
Learn how Type A insulin resistance syndrome changes over time, including diabetes risk, long-term monitoring, family testing, and pregnancy planning.
Common questions in this guide
What causes Type A Insulin Resistance Syndrome?
What signs can suggest that I have TAIRS?
Why can TAIRS cause both high blood sugar and crashes after meals?
How is TAIRS distinguished from PCOS?
Which specialists may help manage Type A Insulin Resistance Syndrome?
Should my biological relatives be tested for TAIRS?
Get notified when new evidence is published on Insulin-resistance syndrome type A.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.
Lin L, Chen C, Fang T, et al.
Journal of medical case reports 2019; (13(1)):347 doi:10.1186/s13256-019-2304-4.
PMID: 31771632 - 2
A New Mutation of the INSR Gene in a 13-Year-Old Girl with Severe Insulin Resistance Syndrome in China.
Jin J, Liang X, Wei J, Xu L
BioMed research international 2021; (2021()):8878149 doi:10.1155/2021/8878149.
PMID: 33728347 - 3
A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation.
Ji C, Zheng X, Wang Q, Chen Z
Frontiers in endocrinology 2026; (17()):1840942 doi:10.3389/fendo.2026.1840942.
PMID: 42272804 - 4
Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report.
Ding Q, Liang M
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2020; (36(6)):558-560 doi:10.1080/09513590.2019.1707794.
PMID: 31899992 - 5
Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance.
Marcelino do Nascimento R, Dos Santos A, Guadagnini D, et al.
Frontiers in endocrinology 2026; (17()):1716020 doi:10.3389/fendo.2026.1716020.
PMID: 42181197 - 6
Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion.
Verdecchia F, Akcan N, Dastamani A, et al.
Hormone research in paediatrics 2020; (93(6)):396-401 doi:10.1159/000510462.
PMID: 33040071 - 7
Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation
Poon SWY, Chung BHY, Wong MSC, Tsang AMC
Journal of clinical research in pediatric endocrinology 2025; (17(1)):115-119 doi:10.4274/jcrpe.galenos.2023.2022-12-10.
PMID: 37074094 - 8
Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.
Martínez-Montoro JI, Pinzón-Martín JL, Damas-Fuentes M, et al.
Frontiers in endocrinology 2022; (13()):838887 doi:10.3389/fendo.2022.838887.
PMID: 35498407
This page is for informational purposes only and does not constitute medical advice. A clinical genetics or endocrinology team should interpret your INSR results and guide care for your specific situation.